Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1 Gastrointestinal 1

Conditions

Stomach Neoplasms 1

Interventions

Oxaliplatin 300 Fluorouracil 273 Bevacizumab 238 Gemcitabine 236 Leucovorin 213 Capecitabine 207 pembrolizumab 202 Irinotecan 159 Nivolumab 158 Cisplatin 150 Specimen Handling 144 Magnetic Resonance Spectroscopy 130 130-nm albumin-bound paclitaxel 119 Paclitaxel 109 durvalumab 107 Cetuximab 104 Radiotherapy 99 atezolizumab 94 Drug Therapy 94 Biopsy 93 tislelizumab 81 Albumin-Bound Paclitaxel 81 Taxes 74 Folfox protocol 68 lenvatinib 67 Carboplatin 66 regorafenib 60 Blood Specimen Collection 60 sintilimab 54 Ipilimumab 53

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Premedication × Gastrointestinal × 1 year × Clear all

NCT07245095 2025-11-24

NACSIMET

Hospital General de Mexicali

Phase 2 Recruiting

Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡